Thursday, December 4, 2008 - 3:58PM EST

General Interest Articles

21. Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson's disease.

Author
Wullner U; Schmitz-Hubsch T; Abele M; Antony G; Bauer P; Eggert K;
Institution
Department of Neurology, UKB, Bonn, Germany.
Journal
J Neural Transm. 2007 May 18;.
Abstract URL
Click here to view abstract

22. The effect of age of onset of PD on risk of dementia.

Author
Aarsland D; Kvaloy JT; Andersen K; Larsen JP; Tang MX; Lolk A; Kragh-Sorensen P; Marder K;
Institution
Norwegian Centre for Movement Disorders, Stavanger University Hospital, Arm Hansen v 20, N-4005, Stavanger, Norway. daa@sir.no
Journal
J Neurol. 2007 Jan;254(1):38-45. Epub 2007 Feb 14.
Abstract URL
Click here to view abstract

23. Current advances in the treatment of Parkinson's disease with stem cells.

Author
Trzaska KA; Rameshwar P;
Institution
UMDNJ-New Jersey Medical School, Department of Medicine, Newark, NJ 07103, USA.
Journal
Curr Neurovasc Res. 2007 May;4(2):99-109.
Abstract URL
Click here to view abstract

24. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.

Author
Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C;
Institution
Movement Disorders Unit and Parkinson Centre, Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Journal
J Psychopharmacol. 2007 Apr 19;.
Abstract URL
Click here to view abstract

25. Treatment of Levodopa-induced Dyskinesia.

Author
Rao J;
Institution
Jayaraman Rao, MD Parkinson's Disease and Movement Disorders Center, Department of Neurology, Ochsner Foundation Clinic, 1514 Jefferson Highway, New Orleans, LA 70121, USA. jrao@ochsner.org.
Journal
Curr Treat Options Neurol. 2007 May;9(3):205-209.
Abstract URL
Click here to view abstract

26. Nutritional therapies in Parkinson's disease.

Author
Evatt ML;
Institution
Marian L. Evatt, MD Department of Neurology, Movement Disorders Section, Emory University School of Medicine, 1841 Clifton Road NE, Atlanta, GA 30329, USA. marian.evatt@emoryhealthcare.org.
Journal
Curr Treat Options Neurol. 2007 May;9(3):198-204.
Abstract URL
Click here to view abstract

27. Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease.

Author
Hancock DB; Martin ER; Stajich JM; Jewett R; Stacy MA; Scott BL; Vance JM; Scott WK;
Institution
Center for Human Genetics and Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Journal
Arch Neurol. 2007 Apr;64(4):576-80.
Abstract URL
Click here to view abstract

28. Prevalence and treatment strategies of dyskinesia in patients with Parkinson's disease.

Author
Muller T; Woitalla D; Russ H; Hock K; Haeger DA;
Institution
Department of Neurology, St Josef Hospital, Ruhr University, Bochum, Germany.
Journal
J Neural Transm. 2007 Apr 10;.
Abstract URL
Click here to view abstract

29. Estimated life expectancy of Parkinson's patients compared with the UK population.

Author
Ishihara LS; Cheesbrough A; Brayne C; Schrag A;
Institution
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Journal
J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1304-9. Epub 2007 Mar 30.
Abstract URL
Click here to view abstract

30. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.

Author
Voon V; Thomsen T; Miyasaki JM; de Souza M; Shafro A; Fox SH; Duff-Canning S; Lang AE; Zurowski M;
Institution
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. voonv@ninds.nih.gov
Journal
Arch Neurol. 2007 Feb;64(2):212-6.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4